Wang A, et al. Evaluation of kidney function before and after percutaneous mitral valve repair. Circ Cardiovasc Interv 2015; 8:e001349.
Feldman T, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364:1395–1406.
Whitlow PL, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59:130–139.
Estévez-Loureiro R, et al. Effect of advanced chronic kidney disease in clinical and echocardiographic outcomes of patients treated with MitraClip system. Int J Cardiol 2015; 198:75–80.
Ohno Y, et al. Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: Insights from the GRASP registry. EuroIntervention 2016; 11:e1649–e1657.
Kaneko H, et al. Interaction between kidney function and percutaneous edge-to-edge mitral valve repair using MitraClip. J Cardiol 2017; 69:476–482.
Shah B, et al. Outcomes after transcatheter mitral valve repair in patients with kidney disease. Circ Cardiovasc Interv 2019; 12:e007552.
Enriquez-Sarano M, et al. Mitral regurgitation. Lancet 2009; 373:1382–1394.
Samad Z, et al. Prevalence and outcomes of left‐sided valvular heart disease associated with chronic kidney disease. J Am Heart Assoc 2017; 6:e006044.